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ABSTRACT
Ribosomal protein L2 is a core element of the large
subunit that is highly conserved among all three
kingdoms. L2 contacts almost every domain of the
large subunit rRNA and participates in an intersub-
unit bridge with the small subunit rRNA. It contains a
solvent-accessible globular domain that interfaces
with the solvent accessible side of the large subunit
that is linked through a bridge to an extension
domain that approaches the peptidyltransferase
center. Here, screening of randomly generated
library of yeast RPL2A alleles identified three
translationally defective mutants, which could be
grouped into two classes. The V48D and L125Q
mutants map to the globular domain. They strongly
affect ribosomal A-site associated functions, pepti-
dyltransferase activity and subunit joining. H215Y,
located at the tip of the extended domain interacts
with Helix 93. This mutant specifically affects
peptidyl–tRNA binding and peptidyltransferase
activity. Both classes affect rRNA structure far
away from the protein in the A-site of the peptidyl-
transferase center. These findings suggest that
defective interactions with Helix 55 and with the
Helix 65–66 structure may indicate a certain degree
of flexibility in L2 in the neck region between the two
other domains, and that this might help to coordi-
nate tRNA–ribosome interactions.
INTRODUCTION
Even well after the discovery of RNA catalysis (1), it was
thought that peptidyltransfer was catalyzed by a riboso-
mal protein. Indeed, a series of ribosome reconstitution
and ribosomal protein omission experiments had nar-
rowed the candidates to two ribosomal proteins required
for this activity: L2 and L3 (2–4). Early chemical
modiﬁcation experiments particularly implicated L2
(5,6), and later studies focused on speciﬁc histidines
thought to be involved in this process (7–9). In fact,
only after high-resolution crystal structures of ribosomal
large subunits revealed that no ribosomal proteins were
close enough to the tRNA 30 ends to participate in
catalysis that it became clear that this essential activity is
completely catalyzed by RNA (10,11).
Although it does not play a direct role in peptidyl-
transfer, ribosomal protein L2 remains an intriguing
subject of study. L2 is so highly conserved that archae-
bacterial and even the human isoforms of the protein can
be functionally reconstituted into Escherichia coli ribo-
somes (8). Along with L3, L4 and L16 (L10 in
eukaryotes), L2 is a member of a group of core ribosomal
proteins containing acidic globular domains at the
periphery and highly basic extensions penetrating into
the rRNA core of the ribosome that form an X-shaped
protein scaﬀold encased by rRNA (Figure 1). L2 contacts
multiple domains of the large subunit rRNA (12) and
participates in the B7b intersubunit bridge with the 18S
rRNA of the small subunit (13). Its SH3 b-barrel globular
domain participates in the intersubunit bridge, and
interacts mainly with rpL43, and helices 79 and 65. The
middle bridge region of the protein L2 is sheathed in
rRNA, making extensive contacts with many separate
helices, including H33, H65, H66 and H67. The extension
region closely approaches the peptidyl–tRNA in a
particularly strong interaction with the major groove of
helix 93at the PTC (12).
Previous functional studies of L2 were primarily
performed in prokaryotes (2–7,9,14–16), and very little
research has been conducted in eukaryotes. These analyses
were primarily performed using the yeast Saccharomyces
cerevisiae two or more decades ago (15,17–22). Since then
our knowledge and understanding of the relationship
between ribosome structure and function has signiﬁcantly
matured, and the repertoire of molecular genetic,
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to bear on these issues has been greatly expanded. In the
current study, the new tools have been used to revisit yeast
ribosomal protein L2. Screening of a library of randomly
generated L2 alleles identiﬁed three mutants unable to
maintain the yeast ‘Killer’ dsRNA virus, a highly sensitive
indicator of defects in the protein synthetic apparatus.
Molecular genetic, biochemical and structural analyses
revealed that these could be grouped into two general
classes. One group, composed of the V48D and L125Q
mutants, maps to the SH3 b-barrel globular domain of L2
and their biochemical and phenotypic eﬀects appear to
mainly be caused by 60S subunit biogenesis defects,
possibly due to defective interactions with Helix 55, and
the Helix 65–66 structure respectively. The other, H215Y
lies near the tip of the basic extended domain where it
interacts with Helix 93 along the P-site side of the PTC
and aﬀects peptidyl–tRNA binding. This initial foray into
L2 mutagenesis has served to identify regions of the
protein important for translational ﬁdelity and lays the
groundwork for deeper investigations.
MATERIALS AND METHODS
Strains, plasmids and media
The S. cerevisiae strains, and oligonucleotides (IDT,
Coralville, IA, USA) used in this study are shown in
Supplementary Tables S1 and S2. rpl2a and rpl2b gene-
deletion strains were obtained from Invitrogen (Carlsbad,
CA, USA), and L-A and M1 ‘killer’ viruses were
introduced into these strains by cytoplasmic mixing by
mating with kar1-1 strains of opposite mating types as
previously described (23). Plasmids were ampliﬁed in
E. coli strain DH5a. Escherichia coli were transformed
using a calcium chloride method (24) and yeast were
transformed with an alkali cation protocol (25). YPAD,
synthetic complete (SC), synthetic dropout medium (H-),
and 4.7 MB plates for testing the killer phenotype were
used as previously described (26,27).
Construction ofRPL2A clones and ofrpl2A/rpl2B
gene-deletion strains
In yeast, L2 is encoded by two identical genes (RPL2A
and RPL2B). RPL2A was cloned in three segments
(50 UTR, 815bp; ORF, 949bp; and 30 UTR, 270bp) each
separated by unique restriction sites which were added
during PCR, and the resulting product was cloned into
pRS316 (CEN6-URA3) (28) to make pRPL2A-URA3.
The three-segment RPL2A cassette was also cloned into
the pRS315 plasmid (CEN6-LEU2) to generate pRPL2A-
LEU2. This is diagrammed in Supplementary Figure S1.
In parallel, haploid strains of opposite mating type
each harboring a deletion of one of the RPL2 isogenes
(JD1205 and JD1207 transformed with pRPL2A-URA3)
were mated, sporulated and tetrads dissected to obtain
haploid rpl2A, rpl2B double knockout strains supported
by a plasmid borne copy of the gene from pRPL2A-
URA3. These were conﬁrmed by their inability to grow
in the presence of 5-ﬂuoroorotic acid (5-FOA).
Generationof rpl2Amutants
Mutations in the RPL2A ORF were generated by both
random mutagenesis and site-directed mutagenesis tech-
niques. Site-directed mutagenesis was carried out using the
Quikchange XL site-directed mutagenesis kit following the
directions of the manufacturer (Stratagene, Madison, WI,
USA). Random mutagenesis of the RPL2A ORF was
performed using an error-prone PCR and gap-repair
procedure (29). The Stratagene Genemorph II Random
Mutagenesis Kit (Stratagene, La Jolla, CA, USA) was
utilized and reaction conditions were optimized for 1–3
mutations/1000nt. The primers (forward: RPL2ARMF
and reverse: RPL2ARMR, see Supplementary Table S2)
included the RPL2A start and stop codons and were
complementary to the 50 and 30 untranslated regions of the
gene. The PCR products were cotransformed into yeast
along with BamHI/SpeI linearized pRPL2A-LEU2 that
contained only the 50 and 30 UTR regions of RPL2A. Cells
were then plated onto medium lacking leucine (–leu) to
select for recombinant clones containing mutant rpl2A
alleles. Colonies were subsequently replica plated onto
media containing 5-FOA to select for cells that had lost
pRPL2A-URA3, leaving colonies expressing pRPL2A-
LEU2 clones. RPL2A was chosen for use instead of
RPL2B because of prior data showing that expression of
RPL2A as the only gene-encoding L2 resulted in appar-
ently wild-type cells, while expression of RPL2B as the sole
form of the protein promoted a slow growth phenotype
and decreased accumulation of 60S subunits (21).
As an initial screen for defects in the translational
apparatus,  10000 colonies were tested for their inability
to maintain the killer virus as previously described. Killer
assays were performed by replica plating test colonies onto
4.7-MB plates seeded with a lawn of killer-susceptible
5 47 indicator cells (23). Plasmids were rescued from
L4
L2
L16 (L10e)
PTC
L3
CP
Figure 1. Crown view of the large ribosomal subunit. Ribosomal
proteins L2, L3, L4 and L16 (eukaryotic ribosomal protein L10) are
indicated. PTC denotes the peptidyltransferase center. CP denotes the
central protuberance. The image was generated with PyMol using the
yeast cryo-EM-based ribosome mapped onto the H. marismoutui X-ray
crystal structure (13).
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 ;
or Killer reduction K
r), ampliﬁed in E. coli, reintroduced
into JD1269, the wild-type pRPL2A-URA3 was elimi-
nated using 5-FOA and killer assays were repeated.
Temperature response, drugsensitivity and growth curves
Dilution spot assays were used to qualitatively monitor
cell growth at various temperatures and drug concentra-
tions. For all conditions, yeast cells were grown to
logarithmic growth phase and then diluted to 1 10
6
CFU/ml. Subsequently, 10-fold serial dilutions of each
strain were spotted onto YPAD and incubated at 158,3 0 8
and 378C, or onto YPAD containing paromomycin (5mg/
ml) or anisomycin (20mg/ml). Sensitivity to sparsomycin
was monitored using a ﬁlter disc assay (30). Yeast cells
were grown overnight to saturation and 300ml of cells
diluted to OD595=0.2 were spread onto YPAD plates
and allowed to dry, after which sterile 6-mm Whatman
ﬁlter discs saturated with 30mg of sparsomycin were
placed onto the center of the plates. Growth curves were
generated in quadruplicate with a Synergy HT micro-plate
reader utilizing the KC4 software package (Bio-Tek
Instruments, Inc., Winooski, VT). Yeast growth at 308C
was measured in 48-well plates beginning with 0.5-ml
cultures of cells in –leu medium diluted to OD595=0.05.
Cultures were subjected to constant high-intensity shaking
and automatic OD595 readings were taken of each well at
20-min intervals for 40h. Duplicate cultures were inde-
pendently assayed twice and the four readings were
averaged for each time point.
Translational fidelity assays
Eﬀects of rpl2A mutants on translational ﬁdelity were
assayed by monitoring their eﬀects on the ability to
suppress an in-frame UAA codon (nonsense suppression),
programmed  1, and +1 ribosomal frameshifting (PRF)
using previously described methods (31). The reporter
constructs are shown in Supplementary Figure S1. The test
construct for  1 PRF includes the  1 PRF signal from the
yeast L-A virus, and translation of the downstream ﬁreﬂy
luciferase gene requires a  1 frameshift event. The +1
PRF test construct contains the +1 PRF signal from the
Ty1 yeast retrotransposable element, and synthesis of the
downstream ﬁreﬂy gene requires a +1 shift in reading
frame. Nonsense suppression was measured by simply
inserting an in-frame stop codon between the Renilla and
ﬁreﬂy luciferase genes, so that a readthrough event is
necessary for expression of the downstream ﬁreﬂy lucifer-
ase. The readthrough control plasmid supplied the baseline
data to which the data from test constructs were compared.
Reaction reagents were from the Dual-Luciferase
Reporter Assay System (Promega Corporation, Madison,
WI, USA) and luminescence readings were measured by a
TD20/20 luminometer (Turner Designs Inc. Sunnyvale,
CA, USA). Each individual assay compares a ratio of two
luciferase (ﬁreﬂy and Renilla) intensities from the test
construct to a 0-frame control plasmid. The ratio of this
test to the control was calculated and normalized to the
wild-type value, with enough replicates for >95%
conﬁdence (minimum of nine replicates). All calculations
and standard errors were determined as previously
described (32).
Ribosome biochemistry
Lysates of cycloheximide arrested yeast cells were
sedimented through 7–47% sucrose gradients and poly-
some proﬁles were determined by monitoring A254nm as
previously described (33). Yeast phenylalanyl–tRNA was
purchased from Sigma (St Louis, MO, USA), charged
with [
14C]-Phe or Ac-[
14C]-Phe and puriﬁed by HPLC as
previously described (34). Ribosomes were isolated from
isogenic wild-type and mutant cells, and puromycin
reactions to monitor peptidyltransferase activity, and
tRNA-binding studies were carried out as previously
described (34). Puriﬁed ribosomes were chemically probed
with dimethylsulfate (DMS), kethoxal or carbodiimide
metho-p-toluenesulfonate (CMCT), followed by reverse
transcriptase primer extension analyses of modiﬁed
rRNAs as previously described (35) with the modiﬁcations
that (i) reactions were performed at 308C instead of 378C
and (ii) low concentrations of deoxyribonucleotides were
employed to maximize reverse transcriptase strong stops
(36). Primer 25-6 was used for analysis of helices 89–93,
and primer 25-11 covered helices 73–74 of 25S rRNA. The
molecular visualization tool Pymol (37) was used to view
and examine available crystal structures of the ribosome.
Images in this document are based primarily on structures
from (13), in which atomic resolution crystal structures
from Haloarcula marismortui and Thermus thermophilus
were docked into cryo-EM structures from S. cerevisiae
(pdb accession numbers 1s1h and 1s1i).
RESULTS
Generation and geneticcharacterization of rpl2Aalleles
Random PCR mutagenesis was used to generate a library
of rpl2a alleles. PCR products and linearized EcoRI/SpeI
digested pPRL2A-LEU2 were introduced into JD1315
cells, transformants were initially selected for growth on –
leu medium and then replica plated to medium containing
5-FOA. Preliminary analysis using 5-FOA revealed that
 30% of the mutants were not viable as the sole form of
rpl2a. All mutations created both in random mutagenesis
and later site-directed mutagenesis are catalogued in
Supplementary Table S3. Maintenance of the endogenous
yeast M1 dsRNA satellite virus is sensitive to a wide
variety of defects in the translational apparatus including
changes in 60S ribosomal biogenesis (38) and to changes
in rates of  1 PRF eﬃciency (23). The latter can in turn be
caused by changes in tRNA binding, peptidyltransferase
activity and interactions between ribosomes and numer-
ous trans-acting factors (39). Thus, mutants were initially
screened for ‘Killer’ phenotypic defects. We note however,
that this screen cannot detect other translational defects,
e.g. in translational initiation or mRNA decay (40). Of
 10000 candidate colonies screened, 79 initially displayed
Killer loss (K
 ) or Killer reduced (K
r) phenotypes.
Plasmids were rescued from these colonies, reintroduced
into JD1315 cells, and taken again through the selection
and Killer analysis protocols. This analysis revealed that
1828 Nucleic Acids Research, 2008, Vol. 36, No. 616 of the mutants conferred K
 , and 20 promoted K
r
phenotypes. These are summarized in Supplementary
Table S3.
The majority of the Killer-defective rpl2A alleles
contained multiple mutations and resulting amino acid
changes, with 22 of the alleles having three or more
mutations. Two alleles had mutations in their stop codons,
resulting in C-terminal extensions containing an extra four
amino acids (YIMY). Six strains had double mutations
and six alleles contained single mutations. Based on the
frequency with which individual mutations occurred, and
their locations within the structure of L2, 16 alleles
harboring single mutations were generated for further
analysis using oligonucleotide site-directed mutagenesis.
Three of the rpl2A single mutant alleles, V48D, L125Q
and H215Y conferred K
– phenotypes (Figure 2A) and
were used for all subsequent analyses. Ten-fold serial
dilution spot assays at 158,3 0 8 and 378C revealed that the
V48D and L125Q mutants grew slower than wild-type
across all tested temperatures with the most pronounced
eﬀects at 378C (Figure 2B). To obtain a higher-resolution
perspective of the eﬀects the mutants, cellular growth
curves were generated at 308 over a period of 40h
(Figure 2C). This analysis revealed that the V48D and
L125Q mutants promoted slower growth rates and failed
to approach the density of the saturated wild type
cultures. The H215Y mutant also promoted decreased
growth rates in logarithmic phase, but was able to attain
saturation concentration similar to wild-type cells.
Growth curves of all 16 of the single mutant strains are
shown in Supplementary Figure S2. Notably, all of the
mutants showed changes in growth rates.
The eﬀects of three translational inhibitors were also
assayed on the three mutants and compared to wild type.
Dilution spot assays revealed that the V48D and L125Q
were similar in their responses to all three drugs:
hypersensitive to paromomycin, strongly resistant to
anisomycin and having wild-type responses to sparsomy-
cin (Figure 2D). In contrast, while H215Y was slightly
anisomycin-resistant, it was signiﬁcantly resistant to
sparsomycin, while paromomycin had no eﬀect relative
to wild-type cells. The results of these genetic studies
indicated that, although all three mutants promoted the
K
  phenotype, they could be divided into two classes:
V48D and L125Q were similar to one another, while
H215Y was unique.
The V48D, L125Q and H215Ymutants promote specific
translational fidelity defects
To test whether changes in rates of  1 PRF were
responsible for the K
  phenotype, isogenic cells expressing
wild-type or mutant forms of L2 were transformed
with either a  1 PRF reporter plasmid harboring the
yeast L-A viral  1 PRF signal, or an in-frame control
(Supplementary Figure S1), and rates of  1 PRF were
monitored as described in the Materials and Methods
section. The results of these experiments are summarized
in Figure 3. The baseline  1 PRF rate in wild-type cells
was 6.29 0.15%. The V48D mutation promoted
10.10+0.52% PRF (1.6-fold wild-type, p=8.5 10
–5),
L125Q promoted 8.49+0.42% (1.4-fold increase,
p=2.2 10
 3), and  1 PRF in H215Q cells was
7.23+0.31 (1.2-fold WT, p=0.01). Programmed +1
frameshifting was similarly monitored using a reporter
harboring the Ty1 +1 PRF signal (Figure 3). The baseline
rate of +1 PRF rate was 13.65 0.43%. The V48D,
L125Q and H215Y mutants did not signiﬁcantly aﬀect this
aspect of translational recoding. Speciﬁcally, +1 PRF for
V48D was 15.55+0.64% (1.1-fold WT); L125Q was
14.45+0.82% (1.0-fold WT), and H215Y was
13.52+0.53 (1.0-fold WT).
Hypersensitivity to paromomycin is often accompanied
by changes in the ability of ribosomes to properly
recognize and decode termination codons. Thus, a dual
luciferase assay was used to monitor the eﬀects of the L2
mutants on nonsense suppression. This reporter is
diagrammed in Supplementary Figure S1. Consistent
with their paromomycin hypersensitivity, the V48D and
L125 mutants promoted increased rates of stop-codon
readthrough (Figure 3). Speciﬁcally, nonsense suppression
rates in cells expressing wild-type L2 were 3.41+0.15%,
while these values were 4.92+0.20% (1.4-fold WT,
p=2.8 10
–4), and 4.5+0.23 (1.3-fold WT,
p=5.8 10
–3) for the V48D and L125Q mutants,
respectively. In contrast, the H215 mutant did not aﬀect
nonsense suppression (3.76+0.14%, 1.1-fold WT,
p=0.1) consistent with its wild-type phenotype with
respect to paromomycin sensitivity.
TheV48DandL125Qmutantspromotestrongdefectsin60S
biogenesis andpolysome profiles
Since loss of the Killer phenotype has also been associated
with 60S biogenesis defects (38), S30 fractions of
cycloheximide-arrested cell lysates were sedimented
through linear 7–47% sucrose gradients ribosomes to
examine the eﬀects of the mutants on this parameter. A254
tracings of the fractionated gradients are shown in
Figure 4. Notably, the proﬁle of the ‘wild-type’ strain
showed slight defects typically associated with 60S subunit
defects. Speciﬁcally, these were (i) decreased 60S peak
heights relative to 40S peak heights, and (ii) the presence
of small ‘shoulders’ on the right sides of the 80S and
polysome peaks indicative of half-mer formation.
Shoulders and half-mer peaks indicate a population of
mRNAs with an extra 40S subunit compared to the
associated primary peak. The extra mass is due to a 40S
subunit stalled at the start codon either due to a shortage
of 60S subunits, or a subunit-joining defect. We believe
that this is an artifact of expression of only one isoform of
L2, consistent with recent ﬁndings of specialized roles for
diﬀerent ribosomal protein isoforms in yeast (41). The
polysome proﬁle of the H215Y mutant was not signiﬁ-
cantly diﬀerent from those of cells expressing wild-type
L2. In contrast, the 60S and half-mer defects were strongly
accentuated in the polysome proﬁles of cells expressing the
V48D and L125Q mutations.
Ribosomebiochemistry
Anisomycin and sparsomycin are peptidyltransferase
inhibitors that target and aﬀect interactions of aa–tRNA
Nucleic Acids Research, 2008, Vol. 36, No. 6 1829and peptidyl–tRNAs with the ribosomal A- and P-sites,
respectively (42). In contrast, paromomycin targets the
decoding center in the small subunit (43), which can aﬀect
the overall interaction of aa–tRNA with the ribosome.
Thus, changes in the interactions between ribosomes and
tRNAs at the biochemical level can manifest themselves at
the biological level as changes in cellular drug sensitivity.
To determine the eﬀects of the mutants on ribosome-
tRNA interactions, ﬁlter-binding assays were performed
under equilibrium conditions to determine dissociation
constants of aa–tRNA to the A-sites and of Ac–aa–tRNA
to the P-sites of wild-type and mutant ribosomes. The
results of these experiments are shown in Figure 5.
Binding of aa–tRNA to the A-site was signiﬁcantly
30° 37° 15°
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V48D
L125Q
H215Y
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H215Y
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D
Figure 2. The L2 mutants promote numerous phenotypic defects. (A) ‘Killer’ virus phenotypes. The Killer
+ phenotype is scored by the presence of a
halo of growth inhibition around wild-type colony. Lack of the halo around colonies expressing the V48D, L125Q and H215Y L2 mutants indicates
the Killer
  phenotype. (B) Ten-fold dilutions of indicated cells were spotted onto rich medium and incubated at the indicated temperatures. (C) Yeast
cell growth was monitored for 40h at 308C with a Synergy HT micro-plate reader and growth curves were generated from four independent readings
utilizing the KC4 software package. (D) Drug-sensitivity phenotypes. To monitor changes in sensitivity to paromomycin and anisomycin, 10-fold
serial dilutions of each strain were spotted onto rich medium containing these drugs at the indicated concentrations. Sensitivity to sparsomycin was
monitored using 6-mm Whatman ﬁlter discs saturated with 30mg of sparsomycin placed onto the center of plates seeded with OD595=0.2 of yeast
cells expressing the indicated L2 mutants.
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Speciﬁcally, while the Kd for aa–tRNA in wild-type
ribosomes was 256.6+35.1nM, Kd values were  0.4-
fold and  2.7-fold (98.5+12.3nM and 688.6+62.8nM)
of wild-type for V48D and L125Q ribosomes, respectively.
Notably, these mutants displayed changes in phenotypes in
response to the A-site speciﬁc drugs anisomycin and
paromomycin. The H215Y mutant, which did not promote
A-site drug-speciﬁc defects, did not signiﬁcantly aﬀect
ribosome–aa–tRNA interactions (Kd=262.2+19.1nM).
In contrast, this mutant was resistant to the P-site speciﬁc
inhibitor sparsomycin, consistent with its ability to
promote a >1.8-fold increase in Kd for Ac–aa–tRNA
(320.4+42.8nM) as compared to wild-type ribosomes
(173.6+22.2nM) (Figure 5B). The V48D and L125Q
mutants did not aﬀect this parameter (156.6+19.4nM
and 167.7+14.1nM, respectively). All of the mutants
negatively impacted ribosomal peptidyltransferase activity
(Figure 5C). Speciﬁcally, Kobs of wild-type ribosomes was
0.16+0.2min
 1, while the values for the V48D, L125Q
and H215Y mutants were 0.07+0.01min
–1,
0.6+0.01min
–1 and 0.04+0.01min
–1, respectively.
These ﬁndings are consistent with previous observations
that decreased rates of peptidyltransfer can stimulate  1
PRF (44).
The L2mutants affectrRNA structure in thevicinity of the
peptidyltransferase center
Given the eﬀects of the mutants on ribosome biochem-
istry, chemical protection methods were used to probe for
changes in rRNA structure in the peptidyltransferase
center. Ribosomes puriﬁed from wild-type and mutant
cells were probed for structural changes using DMS,
kethoxal and CMCT. rRNAs were extracted, and
modiﬁed bases were identiﬁed by primer extension using
reverse transcriptase to detect methylation at the N1
position of adenosines and N3 position of cytidines
(DMS), at the N1 and N2 positions of guanosines
(kethoxal), and at the N3 position of uridines and the
N1 position of guanosines (CMCT) (1). The primers used
(see Materials and Methods section) were designed to
probe rRNA bases in the PTC that interact with peptidyl-
and aa–tRNAs, (from 50 to 30 Helix 89–Helix 73). Changes
in chemical protection patterns are observed as changes in
band intensities 1nt 50 of the modiﬁed base due to the
inability of reverse transcriptase to utilize modiﬁed bases.
The results of these experiments are shown in Figure 6A
and mapped onto a 2-dimensional representation of yeast
25S rRNA in Figure 6B. In Helix 90, all three of the
mutants promoted hyperprotection of U2935 (E. coli
A2566) and deprotection of G2942 (E. coli G2574). Also
in this region, G2938 (E. coli G2570) was deprotected by
both the V48D and L125Q mutants, while it 50 neighbor
G2937 (E. coli G2560) was only deprotected in L125Q
ribosomes. In Helix 93, all three mutants promoted
40S
40S
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60S
60S 60S
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80S
80S
80S
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Polysomes
1/2-mers 1/2-mers
WT L125Q V48D H215Y
7% 47%
Sucrose gradient
Figure 4. The V48D and L125Q mutants promote strong 60S biogenesis and subunit-joining defects. Cytoplasmic extracts from isogenic strains were
loaded onto 7–47% sucrose gradients, centrifuged in an SW41 rotor at 40000 r.p.m. for 180min at 48C, fractionated and analyzed by continuous
monitoring of A254 (48). The locations of 40S, 60S, 80S, polysome fractions and half-mers are labeled. The presence of half-mers is indicative of
subunit-joining defects.
0
2
4
6
8
10
12
14
16
18
WT V48D L125Q H215Y
R
e
c
o
d
i
n
g
,
 
p
e
r
c
e
n
t
−1 PRF Nons-suppr. +1 PRF
p < 
0.01
p = 
0.01
p < 
0.01
p < 
0.01
p < 
0.01
Figure 3. The L2 mutants promote speciﬁc defects in translational
ﬁdelity. Isogenic yeast cells expressing either wild-type or mutant forms
of L2 were transformed with the dual luciferase reporter and control
plasmids shown in Supplementary Figure S1 and rates of translational
recoding were determined.  1 PRF indicates percent of programmed
 1 ribosomal frameshifting promoted by the yeast L-A virus frameshift
signal. +1 PRF denotes programmed +1 ribosomal frameshifting
directed by the frameshift signal of the Ty1 retrotransposable element.
Nons-suppr. denotes the percentage of ribosomes able to suppress an
in-frame UAA termination codon located between the Renilla and
ﬁreﬂy luciferase reporter genes. p values are indicated above samples
showing statistically signiﬁcant changes. Error bars denote SE as
previously described (32).
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and H215Y mutants promoted slightly greater levels of
deprotection of C2985 (E. coli C2616) in Helix 73.
Mapping of these changes onto the 3-dimensional
structure of yeast L2 as determined by cryo-EM and
ﬁtted into the H. marismortui 50S X-ray crystallographic
structure (13) reveal that all of the other bases are
clustered in the A-site region of the PTC, with the
exception of G2972 which is located near the P-site
(Figure 6C).
DISCUSSION
The goal of this study was to create a library of yeast
ribosomal protein L2 mutants and identify structurally
and functionally important amino acid residues. Screening
for loss of the killer virus as a general indicator of
defective ribosome function allowed high-throughput
identiﬁcation of randomly generated mutants that con-
ferred translational defects. Most of the mutants so
identiﬁed contained mutations of more than one amino
acid residue. While it is possible that multiple mutations
could have been caused by the random mutagenesis
protocol, this is unlikely as primer concentrations and
reaction conditions were adjusted to generate primarily
single mutations. Although only strains containing single
mutations were selected for further study, the fact that
multiple amino acid changes were generally necessary to
promote killer virus loss suggests that this protein, which
is ﬁrmly integrated in the large subunit through contacts
with multiple domains of 25S rRNA, is functionally and
structurally robust. This hypothesis is supported by the
observation that human and archael L2 proteins were
functional in E. coli ribosomes (8). The observations that
all of the single mutants impacted cell growth
(Supplementary Figure S2), and that its expression as
the sole form of the protein resulted in a subtle 60S
subunit biogenesis defect as manifested by decreased 60S
peak heights relative to 40S and small half-mer peaks,
suggest that that both the structure and expression of L2
has been ﬁne-tuned to promote optimal cell growth in
yeast.
Although all three of the single mutants promoted
decreased peptidyltransferase activities, thus stimulating
 1 PRF and loss of the killer virus, diﬀerences in other
genetic biochemical, and sturctural aspects allow them to
be grouped into two classes: V48D and L125Q versus
H215Y. V48D and L125Q are both located on the surface
of the globular domain of L2, near the ‘neck’ region
linking it to the extended domain, and immediately
adjacent to two helices of 25S rRNA (Figure 6C). Both
mutants change small aliphatic side chains which should
minimally interact with nucleoside bases to larger, polar
(acidic and amide) side chains that could cause changes in
both the local stereochemical and biochemical interactions
with the Helix 55 and Helix 65–66. These helices appear to
anchor the globular domain of L2 into the large subunit,
and it is reasonable to conjecture that altering these
interactions could propagate outward, resulting in more
severe functional and biological defects. This is supported
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Figure 5. The L2 mutants aﬀect tRNA binding and peptidyltransferase
activity. (A) Dissociation constants generated by analysis of single-site-
binding isotherms of eEF-1A stimulated binding of [
14C]Phe-tRNA to
ribosomal A-sites. (B) Dissociation constants generated by analysis of
single-site-binding isotherms of Ac-[
14C]Phe-tRNA to ribosomal P-sites.
(C) Characterization of peptidyltransferase activities of wild-type and
mutant ribosomes generated by analyses of ﬁrst order time plots of
Ac-[
14C]Phe-puromycin formation. Error bars denote mean and standard
deviation.
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Nucleic Acids Research, 2008, Vol. 36, No. 6 1833by the decreased growth rates, strong 60S biogenesis, and
subunit-joining defects associated with the V48D and
L125Q mutants. A recent study in E. coli showing that
Helix 66 mutants promoted similar subunit association
defects, and that the architecture of H66 rather than of its
base sequence was the most important parameter (45)
provides a complementary supporting dataset. The V48D
and L125Q mutants appeared to impact on A-site-speciﬁc
functions as manifested by their altered sensitivities to
paromomycin and anisomycin, enhanced suppression of
nonsense-codons and speciﬁc changes in aa–tRNA bind-
ing. In E. coli, it is notable that the D83N mutant
(analogous to D50 in yeast) did not signiﬁcantly aﬀect aa–
tRNA binding but did promote an  28% decrease in
aﬃnity for Ac–aa–tRNA in the P-site (9). The ﬁnding of
structural alterations of bases in the A-site (U2935,
G2937, G2938, G2943 and C2985), and one base in the
P-site (G2972), all located quite distantly from V48 and
L125 is also intriguing. Mutants in the W-ﬁnger domain
and the N-terminal extension of ribosomal protein L3
mutants had similar structural eﬀects on the same region
of Helix 90 (46, Meskauskas and Dinman, unpublished).
These studies have suggested that L3 helps to coordinate
the stepwise processes of translation elongation. It is
tempting to speculate that the opposing eﬀects of the L2
mutants on aa–tRNA binding, and their long-distance
eﬀects on rRNA structure may be indicative of a certain
degree of ﬂexibility in L2 in the neck region between the
two domains which might similarly be involved in
coordinating tRNA–ribosome interactions.
In contrast, the nature and location of the H215Y
mutant distinguish it from the V48D and L125Q mutants.
This amino acid is located at the tip of the internal
extension domain, nestled in the major groove of Helix 93,
proximal to the P-site of the PTC and the binding sites for
anisomycin and sparsomycin (47). Unlike the other two
mutants the H215Y strain was relatively healthy, and its
functional aﬀects, i.e. slight anisomycin resistance, strong
sparsomycin resistance and decreased aﬃnity for Ac–aa–
tRNA, suggests that its eﬀects are more directly targeted
to the PTC. Notably, in E. coli, mutants of D288, H229
and H213 (analogous to yeast D207, H208 and H210),
which map to the tip of the L2 extension, also inhibited
peptidyltransfer and Ac–aa–tRNA binding (9). These
observations recommend this region of L2 for more
detailed reverse-genetics studies by targeting speciﬁc
amino acids across a range of biochemical properties in
order to generate a more detailed picture of how the
structure of L2 contributes to ribosome function.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We thank Rasa Rakauskaite _, Karen Jack, Trey Belew and
Michael Rhodin for their help and insightful comments.
This work was supported by grants to A.M. from the
American Heart Association (AHA 0630163N), and to
J.D.D. from the National Institutes of Health (R01
GM058859). J.R.R. was partially supported by an NIH
training grant (T32 AI051967-05). Funding to pay the
Open Access publication charges for this article was
provided by the National Institutes of Health.
Conﬂict of interest statement. None declared.
REFERENCES
1. Inoue,T., Sullivan,F.X. and Cech,T.R. (1985) Intermolecular exon
ligation of the rRNA precursor of Tetrahymena: oligonucleotides
can function as 50 exons. Cell, 43, 431–437.
2. Kazemie,M. (1976) Binding of aminoacyl-tRNA to reconstituted
subparticles of Escherichia coli large ribosomal subunits. Eur. J.
Biochem., 67, 373–378.
3. Schulze,H. and Nierhaus,K.H. (1982) Minimal set of ribosomal
components for reconstitution of the peptidyltransferase activity.
EMBO J., 1, 609–613.
4. Khaitovich,P., Mankin,A.S., Green,R., Lancaster,L. and
Noller,H.F. (1999) Characterization of functionally active subribo-
somal particles from Thermus aquaticus. Proc. Natl Acad. Sci.
USA, 96, 85–90.
5. Fahnestock,S.R. (1975) Evidence of the involvement of a 50S
ribosomal protein in several active sites. Biochemistry, 14,
5321–5327.
6. Sonenberg,N., Wilchek,M. and Zamir,A. (1973) Mapping of
Escherichia coli ribosomal components involved in peptidyl
transferase activity. Proc. Natl Acad. Sci. USA, 70, 1423–1426.
7. Harada,N., Maemura,K., Yamasaki,N. and Kimura,M. (1998)
Identiﬁcation by site-directed mutagenesis of amino acid residues in
ribosomal protein L2 that are essential for binding to 23S ribosomal
RNA. Biochim. Biophys. Acta, 1429, 176–186.
8. Uhlein,M., Weglohner,W., Urlaub,H. and Wittmann-Liebold,B.
(1998) Functional implications of ribosomal protein L2 in protein
biosynthesis as shown by in vivo replacement studies. Biochem. J.,
331, 423–430.
9. Diedrich,G., Spahn,C.M., Stelzl,U., Schafer,M.A., Wooten,T.,
Bochkariov,D.E., Cooperman,B.S., Traut,R.R. and Nierhaus,K.H.
(2000) Ribosomal protein L2 is involved in the association of the
ribosomal subunits, tRNA binding to A and P sites and peptidyl
transfer. EMBO J., 19, 5241–5250.
10. Yusupov,M.M., Yusupova,G.Z., Baucom,A., Lieberman,K.,
Earnest,T.N., Cate,J.H. and Noller,H.F. (2001) Crystal structure of
the ribosome at 5.5A ˚ resolution. Science, 292, 883–896.
11. Ban,N., Nissen,P., Hansen,J., Moore,P.B. and Steitz,T.A. (2000)
The complete atomic structure of the large ribosomal subunit at
2.4A ˚ resolution. Science, 289, 905–920.
12. Klein,D.J., Moore,P.B. and Steitz,T.A. (2004) The roles of
ribosomal proteins in the structure assembly, and evolution of the
large ribosomal subunit. J. Mol. Biol., 340, 141–177.
13. Spahn,C.M., Beckmann,R., Eswar,N., Penczek,P.A., Sali,A.,
Blobel,G. and Frank,J. (2001) Structure of the 80S ribosome from
Saccharomyces cerevisiae–tRNA- ribosome and subunit-subunit
interactions. Cell, 107, 373–386.
14. Oen,H., Pellegrini,M. and Cantor,C.R. (1974) Peptidyl-transferase
inhibitors alter the covalent reaction of BrAcPhe-tRNA with the
E. coli ribosome. FEBS Lett., 45, 218–222.
15. Wower,J., Hixson,S.S. and Zimmermann,R.A. (1988)
Photochemical cross-linking of yeast tRNA(Phe) containing
8-azidoadenosine at positions 73 and 76 to the Escherichia coli
ribosome. Biochemistry, 27, 8114–8121.
16. Nakagawa,A., Nakashima,T., Taniguchi,M., Hosaka,H.,
Kimura,M. and Tanaka,I. (1999) The three-dimensional structure of
the RNA-binding domain of ribosomal protein L2; a protein at the
peptidyl transferase center of the ribosome. EMBO J., 18,
1459–1467.
17. Perez-Gosalbez,M., Vazquez,D. and Ballesta,J.P. (1978) Aﬃnity
labelling of yeast ribosomal peptidyl transferase. Mol. Gen. Genet.,
163, 29–34.
1834 Nucleic Acids Research, 2008, Vol. 36, No. 618. Reyes,R., Vazquez,D. and Ballesta,J.P. (1978) Structure of the yeast
ribosomes. Proteins associated with the rRNA. Biochim. Biophys.
Acta, 521, 229–234.
19. Kudlicki,W., Szyszka,R., Palen,E. and Gasior,E. (1980) Evidence
for a highly speciﬁc protein kinase phosphorylating two strongly
acidic proteins of yeast 60S ribosomal subunit. Biochim. Biophys.
Acta, 633, 376–385.
20. Otaka,E., Higo,K. and Itoh,T. (1983) Yeast ribosomal proteins:
VII. Cytoplasmic ribosomal proteins from Schizosaccharomyces
pombe. Mol. Gen. Genet., 191, 519–524.
21. Lucioli,A., Presutti,C., Ciafre,S., Caﬀarelli,E., Fragapane,P. and
Bozzoni,I. (1988) Gene dosage alteration of L2 ribosomal protein
genes in Saccharomyces cerevisiae: eﬀects on ribosome synthesis.
Mol. Cell. Biol., 8, 4792–4798.
22. Kudlicki,W., Grankowski,N. and Gasior,E. (1976) Ribosomal
protein as substrate for a GTP-dependent protein kinase from yeast.
Mol. Biol. Rep., 3, 121–129.
23. Dinman,J.D. and Wickner,R.B. (1992) Ribosomal frameshifting
eﬃciency and Gag/Gag-pol ratio are critical for yeast M1 double-
stranded RNA virus propagation. J. Virol., 66, 3669–3676.
24. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular
Cloning, a Laboratory Manual. Cold Spring Harbor Press, Cold
Spring Harbor, NY.
25. Ito,H., Fukuda,Y., Murata,K. and Kimura,A. (1983)
Transformation of intact yeast cells treated with alkali cations.
J. Bacteriol., 153, 163–168.
26. Dinman,J.D. and Wickner,R.B. (1994) Translational maintenance
of frame: mutants of Saccharomyces cerevisiae with altered -1
ribosomal frameshifting eﬃciencies. Genetics, 136, 75–86.
27. Wickner,R.B. and Leibowitz,M.J. (1979) Mak mutants of yeast:
mapping and characterization. J. Bact., 140, 154–160.
28. Sikorski,R.S. and Hieter,P. (1989) A system of shuttle vectors and
yeast host strains designed for eﬃcient manipulation of DNA in
Saccharomyces cerevisiae. Genetics, 122, 19–27.
29. Muhlrad,D., Hunter,R. and Parker,R. (1992) A rapid method for
localized mutagenesis of yeast genes. Yeast, 8, 79–82.
30. Dinman,J.D. and Kinzy,T.G. (1997) Translational misreading:
Mutations in translation elongation factor 1a diﬀerentially aﬀect
programmed ribosomal frameshifting and drug sensitivity. RNA, 3,
870–881.
31. Harger,J.W. and Dinman,J.D. (2003) An in vivo dual-luciferase
assay system for studying translational recoding in the yeast
Saccharomyces cerevisiae. RNA, 9, 1019–1024.
32. Jacobs,J.L. and Dinman,J.D. (2004) Systematic analysis of bicis-
tronic reporter assay data. Nucleic Acids Res., 32, e160–e170.
33. Sachs,A.B. and Davis,R.W. (1989) The poly(A) binding protein is
required for poly(A) shortening and 60S ribosomal subunit-
dependent translation initiation. Cell, 58, 857–867.
34. Meskauskas,A., Petrov,A.N. and Dinman,J.D. (2005) Identiﬁcation
of functionally important amino acids of ribosomal protein L3 by
saturation mutagenesis. Mol. Cell. Biol., 25, 10863–10874.
35. Stern,S., Moazed,D. and Noller,H.F. (1988) Structural analysis of
RNA using chemical and enzymatic probing monitored by primer
extension. Methods Enzymol., 164, 481–489.
36. Lowe,T.M. and Eddy,S.R. (1999) A computational
screen for methylation guide snoRNAs in yeast. Science, 283,
1168–1171.
37. DeLano,W.L. The PyMOL Molecular Graphics System. http://
www.pymol.org. 2006.
38. Ohtake,Y. and Wickner,R.B. (1995) Yeast virus propagation
depends critically on free 60S ribosomal subunit concentration.
Mol. Cell. Biol., 15, 2772–2781.
39. Dinman,J.D. and Berry,M.J. (2006) Regulation of termination and
recoding. In Mathews,M.B., Sonenberg,N. and Hershey,J.W.B.
(eds), Translational Control in Biology and Medicine. Cold Spring
Harbor Press, Cold Spring Harbor, NY.
40. Harger,J.W. and Dinman,J.D. (2004) Evidence against a direct role
for the Upf proteins in frameshﬁting or nonsense codon read-
through. RNA, 10, 1721–1729.
41. Komili,S., Farny,N.G., Roth,F.P. and Silver,P.A. (2007) Functional
speciﬁcity among ribosomal proteins regulates gene expression. Cell,
131, 557–571.
42. Pestka,S. (1977) Inhibitors of protein synthesis. In Weissbach,H.
and Pestka,S. (eds), Molecular Mechanismns of Protein Biosynthesis.
Academic Press, New York, pp. 467–553.
43. Ogle,J.M., Carter,A.P. and Ramakrishnan,V. (2003) Insights into
the decoding mechanism from recent ribosome structures. Trends
Biochem. Sci., 28, 259–266.
44. Meskauskas,A., Harger,J.W., Jacobs,K.L.M. and Dinman,J.D.
(2003) Decreased peptidyltransferase activity correlates with
increased programmed -1 ribosomal frameshifting and viral main-
tenance defects in the yeast Saccharomyces cerevisiae. RNA, 9,
982–992.
45. Kitahara,K., Kajiura,A., Sato,N.S. and Suzuki,T. (2007) Functional
genetic selection of Helix 66 in Escherichia coli 23S rRNA identiﬁed
the eukaryotic-binding sequence for ribosomal protein L2. Nucleic
Acids Res., 35, 4018–4029.
46. Meskauskas,A. and Dinman,J.D. (2007) Ribosomal protein L3:
gatekeeper to the A site. Molecular Cell, 25, 877–888.
47. Hansen,J.L., Moore,P.B. and Steitz,T.A. (2003) Structures of ﬁve
antibiotics bound at the peptidyl transferase center of the large
ribosomal subunit. J. Mol. Biol., 330, 1061–1075.
48. Ohtake,Y. and Wickner,R.B. (1995) KRB1, a suppressor of mak7-1
(a mutant RPL4A), is RPL4B, a second ribosomal protein L4 gene,
on a fragment of Saccharomyces chromosome XII. Genetics, 140,
129–137.
Nucleic Acids Research, 2008, Vol. 36, No. 6 1835